139 related articles for article (PubMed ID: 28124614)
1. Synthesis of Adamantane Aminoethers with Antitubercular Potential.
Foscolos AS; Papanastasiou I; Tsotinis A; Kolocouris N; Foscolos GB; Vocat A; Cole ST
Med Chem; 2017; 13(7):670-681. PubMed ID: 28124614
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of diphenoxyadamantane alkylamines with pharmacological interest.
Georgiadis MO; Kourbeli V; Ioannidou V; Karakitsios E; Papanastasiou I; Tsotinis A; Komiotis D; Vocat A; Cole ST; Taylor MC; Kelly JM
Bioorg Med Chem Lett; 2019 Jun; 29(11):1278-1281. PubMed ID: 30981579
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
[TBL] [Abstract][Full Text] [Related]
6. In vitro Controlled Release from Solid Pharmaceutical Formulations of two new Adamantane Aminoethers with Antitubercular Activity (I).
Vlachou M; Siamidi A; Diamantidi E; Iliopoulou A; Papanastasiou I; Ioannidou V; Kourbeli V; Foscolos AS; Vocat A; Cole ST; Karalis V; Kellici T; Mavromoustakos T
Drug Res (Stuttg); 2017 Aug; 67(8):447-450. PubMed ID: 28561241
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria.
Bhakta S; Scalacci N; Maitra A; Brown AK; Dasugari S; Evangelopoulos D; McHugh TD; Mortazavi PN; Twist A; Petricci E; Manetti F; Castagnolo D
J Med Chem; 2016 Mar; 59(6):2780-93. PubMed ID: 26907951
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv.
Jia L; Coward L; Gorman GS; Noker PE; Tomaszewski JE
J Pharmacol Exp Ther; 2005 Nov; 315(2):905-11. PubMed ID: 16085758
[TBL] [Abstract][Full Text] [Related]
9. [Antiviral agents. 22. N-aliphatic, N-alicyclic and N-polycyclic substituted N'-(2-adamantyl)ureas and -thioureas].
Kreutzberger A; Tantawy A
Arzneimittelforschung; 1983; 33(4):512-4. PubMed ID: 6683528
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs.
Nikonenko BV; Protopopova M; Samala R; Einck L; Nacy CA
Antimicrob Agents Chemother; 2007 Apr; 51(4):1563-5. PubMed ID: 17242141
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines.
Tripathi RP; Saxena N; Tiwari VK; Verma SS; Chaturvedi V; Manju YK; Srivastva AK; Gaikwad A; Sinha S
Bioorg Med Chem; 2006 Dec; 14(24):8186-96. PubMed ID: 17010617
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents.
Patel SR; Gangwal R; Sangamwar AT; Jain R
Eur J Med Chem; 2014 Oct; 85():255-67. PubMed ID: 25089809
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-tuberculosis activity of glycitylamines.
Corkran HM; Dangerfield EM; Haslett GW; Stocker BL; Timmer MS
Bioorg Med Chem; 2016 Feb; 24(4):693-702. PubMed ID: 26810833
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of conformationally constrained analogues of the antitubercular agent ethambutol.
Faugeroux V; Génisson Y; Salma Y; Constant P; Baltas M
Bioorg Med Chem; 2007 Sep; 15(17):5866-76. PubMed ID: 17566744
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives.
Candéa AL; Ferreira Mde L; Pais KC; Cardoso LN; Kaiser CR; Henriques Md; Lourenço MC; Bezerra FA; de Souza MV
Bioorg Med Chem Lett; 2009 Nov; 19(22):6272-4. PubMed ID: 19819134
[TBL] [Abstract][Full Text] [Related]
17. In vitro interactions between new antitubercular drug candidates SQ109 and TMC207.
Reddy VM; Einck L; Andries K; Nacy CA
Antimicrob Agents Chemother; 2010 Jul; 54(7):2840-6. PubMed ID: 20385864
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA
J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
